Cydan II
Latest round
- Series A
Last raised
- Oct 2013
Total raised
- $26M
Investors
- 5
About Cydan II
Cydan II, Inc. is a biopharmaceutical company focused on advancing innovative therapies for rare genetic disorders.Cydan II, Inc. specializes in developing therapies aimed at rare genetic diseases. Founded in 2013, the company is headquartered in Cambridge, US. Chris Adams serves as the CEO. The firm has undergone a strategic focus on rare diseases since its inception. In October 2017, Cydan II, Inc.Cydan II, Inc. focuses on developing therapeutic solutions for rare genetic disorders. Their offerings are centered around pioneering drug candidates that target specific genetic mutations, aiming to address critical gaps in treatment options for affected patients.Cydan II, Inc. generates revenue primarily through partnerships and collaborations with pharmaceutical companies aimed at developing and commercializing its therapeutic products.Cydan II, Inc.00 mn to enhance its drug development pipeline, focusing on the advancement of new product candidates targeting rare genetic disorders. The firm is strategizing to expand its market reach into Europe and Asia by 2025, aiming to establish partnerships with local biopharmaceutical firms. This expansion will facilitate access to new patient populations and accelerate the development of their innovative therapies, ensuring they meet the needs of a broader audience.
Who invested in Cydan II
5 investors across 2 rounds
See all investors in Cydan II
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cydan II
Who invested in Cydan II?
Cydan II has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cydan II raised?
Cydan II has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cydan II last raise money?
Cydan II's most recent round on record is a Series A, in Oct 2013.
What does Cydan II do?
Cydan II is a pharmaceuticals company.
Where is Cydan II headquartered?
Cydan II is headquartered in Cambridge, US.
Which VCs invest in companies like Cydan II?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Cydan II's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Cydan II? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.